T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers Meeting Abstract


Authors: Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
Abstract Title: T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Meeting Title: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Journal Title: Molecular Cancer Therapeutics
Volume: 18
Issue: 12 Suppl.
Meeting Dates: 2019 Oct 26-30
Meeting Location: Boston, MA
ISSN: 1535-7163
Publisher: American Association for Cancer Research  
Date Published: 2019-12-01
Language: English
ACCESSION: WOS:000510047200371
DOI: 10.1158/1535-7163.Targ-19-cn01-03
PROVIDER: wos
Notes: Meeting Abstract: CN01-03 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Martin Gunther Klatt
    8 Klatt
  2. Matthew R Femia
    3 Femia